FDA approves first postpartum depression pill

Norge Nyheter Nyheter

FDA approves first postpartum depression pill
Norge Siste Nytt,Norge Overskrifter
  • 📰 chicagotribune
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 91%

Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.

A pregnant woman stands for a portrait in Dallas, Thursday, May 18, 2023. On Friday, Aug. 4, 2023, U.S. health officials approved the first pill, Zurzuvae, specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.

Postpartum depression affects an estimated 400,000 people a year, and while it often ends on its own within a couple weeks, it can continue for months or even years. Standard treatment includes counseling or antidepressants, which can take weeks to work and don’t help everyone.The new pill is from Sage Therapeutics, which has a similar infused drug that’s given intravenously over three days in a medical facility.

“I planned my pregnancies, I knew I wanted those kids but I didn’t want to interact with them,” said McMahon, who lives in New York City. She says her mood and outlook started improving within days of taking the first pills.Dr. Kimberly Yonkers of Yale University said the Zurzuvae effect is “strong” and the drug likely will be prescribed for women who haven’t responded to antidepressants. She wasn’t involved in testing the drug.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

chicagotribune /  🏆 8. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Regeneron expects FDA decision on high-dose eye drug this year, shares jumpRegeneron expects FDA decision on high-dose eye drug this year, shares jumpRegeneron Pharmaceuticals expects a U.S. decision on a higher-dose version of its blockbuster eye disease drug Eylea in the third quarter, much earlier than market expectations, sending its shares 5% higher in premarket trading on Thursday.
Les mer »

Extreme temperatures aren’t stopping food pantry volunteers from providing cold, fresh foodExtreme temperatures aren’t stopping food pantry volunteers from providing cold, fresh foodHundreds of cars line up the River City Community Center parking lot every Wednesday, waiting for a helping hand. The record-breaking heat is not stopping volunteers from helping people get the food they need.
Les mer »

The biggest names in food are just regular people on TikTokThe biggest names in food are just regular people on TikTokThe millions of followers flocking to folks cooking on newer social media platforms shows a deep interest in cooking, finding inspiration for daily meals, and even in figuring out where to go eat. (via voxdotcom)
Les mer »

The Political Turf Battle Over the Future of Your Prime RibThe Political Turf Battle Over the Future of Your Prime RibThe White House must decide whether the Food and Drug Administration or Agriculture Department will oversee the food-company scientists tweaking genes to make animals heat tolerant, faster growing or disease resistant.
Les mer »

First-ever pill for postpartum depression is up for FDA approval this weekFirst-ever pill for postpartum depression is up for FDA approval this weekThe FDA is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression. If approved, it will become the first treatment that can be taken at home.
Les mer »

First-ever pill for postpartum depression is up for FDA approval this weekFirst-ever pill for postpartum depression is up for FDA approval this weekThe Food and Drug Administration is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression.
Les mer »



Render Time: 2025-03-04 21:40:35